Shorter courses of radiotherapy

Categories: Winter 2023

Between 2004 and 2020, there was a notable change in how doctors treated prostate cancer in the US, as reported in JAMA Oncology. A research team studied data from the National Cancer Database involving 313,062 patients with localized prostate cancer.

By 2020, the most common radiotherapy treatments for low- and intermediate-risk patients were ultrahypo-ractionation and moderate hypofractionation, respectively.

The study also showed that using shorter courses of radiotherapy was more common for patients at community cancer programs compared to academic or research programs, those with Medicaid insurance versus Medicare, Black patients versus White patients, and those with higher incomes.

The authors suggest that making hypofractionation more financially appealing could help more people access this treatment, especially those in underserved communities.

Health Day News. 2023 Oct 10.

Tagged with:

Subscribe to Quest

"*" indicates required fields


This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*